US › Healthcare

iRhythm Technologies Inc (IRTC)

US · Healthcare · Medical Devices

$127.13+1.98%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$199.4M
Revenue YoY
+25.7%
Net profit
$-13.9M
Profit YoY
+54.6%
EPS
$-0.35
EPS estimate
$-0.64
Net margin
-7.0%

EPS came in at -0.35 against a street estimate of -0.64 — a beat of 45.3%.

Key statistics

Market cap
$3.85B
Forward P/E
833.3
P/B
23.88
Book value
$4.91
EPS (TTM)
$-0.86
52-week high
$212.00
52-week low
$100.85
50-day MA
$113.90
200-day MA
$141.68
Beta
1.27

Analyst view

Analysts rate iRhythm Technologies Inc a strong buy (12 buy, 1 hold, 0 sell out of 13) with an average price target of $177.07.

Shareholding

Insiders
1.16%
Institutions
110.61%

Largest institutional holders

FundStake
Vanguard Group Inc10.07%
BlackRock Inc8.34%
Vanguard Portfolio Management, LLC5.47%
RTW INVESTMENTS, LLC5.08%
Millennium Management LLC4.89%
Artisan Partners Limited Partnership4.42%
Vanguard Capital Management, LLC4.40%
FMR Inc4.14%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for iRhythm Technologies Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.